Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan H Moore

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
EMBO Molecular Medicine|November 13, 2012
Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survivalJenny S Henkel, David R Beers, Shixiang Wen, et al.
Journal of Geriatric Oncology|March 12, 2014
Long-term outcomes among African-American and white women with breast cancer: what is the impact of comorbidity?Monika Izano, William A Satariano, Martin C Tammemagi, et al.
BMC Cancer|April 13, 2007
Identification of a robust gene signature that predicts breast cancer outcome in independent data setsJames E Korkola, Ekaterina Blaveri, Sandy DeVries, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2006
Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expressionMark D Sternlicht, Alison M Dunning, Dan H Moore, et al.
Breast Cancer Research and Treatment|October 12, 2012
Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic reviewDejana Braithwaite, Monika Izano, Dan H Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Magnetic resonance imaging captures the biology of ductal carcinoma in situLaura J Esserman, Anjali S Kumar, Alex F Herrera, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 16, 2014
A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALSMichael E Bozik, Hiroshi Mitsumoto, Benjamin R Brooks, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 4, 2016
Phase I clinical trial of safety of L-serine for ALS patientsTodd D Levine, Robert G Miller, Walter G Bradley, et al.
Breast Cancer Research : BCR|September 14, 2007
Aging impacts transcriptomes but not genomes of hormone-dependent breast cancersChristina Yau, Vita Fedele, Ritu Roydasgupta, et al.
Nature Medicine|November 22, 2011
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosisMerit Cudkowicz, Michael E Bozik, Evan W Ingersoll, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
EMBO Molecular Medicine|November 13, 2012
Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survivalJenny S Henkel, David R Beers, Shixiang Wen, et al.
Journal of Geriatric Oncology|March 12, 2014
Long-term outcomes among African-American and white women with breast cancer: what is the impact of comorbidity?Monika Izano, William A Satariano, Martin C Tammemagi, et al.
BMC Cancer|April 13, 2007
Identification of a robust gene signature that predicts breast cancer outcome in independent data setsJames E Korkola, Ekaterina Blaveri, Sandy DeVries, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2006
Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expressionMark D Sternlicht, Alison M Dunning, Dan H Moore, et al.
Breast Cancer Research and Treatment|October 12, 2012
Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic reviewDejana Braithwaite, Monika Izano, Dan H Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Magnetic resonance imaging captures the biology of ductal carcinoma in situLaura J Esserman, Anjali S Kumar, Alex F Herrera, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 16, 2014
A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALSMichael E Bozik, Hiroshi Mitsumoto, Benjamin R Brooks, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 4, 2016
Phase I clinical trial of safety of L-serine for ALS patientsTodd D Levine, Robert G Miller, Walter G Bradley, et al.
Breast Cancer Research : BCR|September 14, 2007
Aging impacts transcriptomes but not genomes of hormone-dependent breast cancersChristina Yau, Vita Fedele, Ritu Roydasgupta, et al.
Nature Medicine|November 22, 2011
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosisMerit Cudkowicz, Michael E Bozik, Evan W Ingersoll, et al.
Pageof 11